CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
40 hedge funds and large institutions have $39.2M invested in CTI BioPharma Corp. (DE) Common Stock in 2019 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
40
Holding in Top 10
1
Calls
$189K
Puts
–
Top Buyers
| 1 | +$427K | |
| 2 | +$283K | |
| 3 | +$142K | |
| 4 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$67.9K |
| 5 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
+$25K |
Top Sellers
| 1 | -$325K | |
| 2 | -$205K | |
| 3 | -$134K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$75.8K |
| 5 |
Squarepoint
New York
|
-$75K |